On April 20, 2026, we announced that we have initiated a review of strategic alternatives to maximize shareholder value and on April 28, 2026, in connection with our review of strategic alternatives, we announced a restructuring of our workforce, or the Restructuring Plan, to decrease operating expenses by reducing the workforce by approximately 75%.

filing / Aug 10, 2026 / receipt

We estimate the aggregate severance and related costs for the Restructuring Plan will be approximately $3.3 million, which was recorded primarily in the second quarter of 2026.

filing / Aug 10, 2026 / receipt

The net gain on lease terminations was a result of the Hopewell Lease Termination Agreement, for the laboratory lease agreement related to our laboratory facility in Hopewell, New Jersey and the 2005 Market Street Lease Termination Agreement, for our office space located in Philadelphia, Pennsylvania.

filing / Aug 10, 2026 / receipt

In January 2025, the Company announced a workforce reduction to reduce operating expenses and to extend its cash runway.

filing / Aug 10, 2026 / receipt

On April 28, 2026, in connection with our review of strategic alternatives, we announced a restructuring of our workforce, or the Restructuring Plan, to decrease operating expenses by reducing the workforce by approximately 75%.

filing / May 12, 2026 / receipt

We estimate the aggregate severance and related costs for the Restructuring Plan will be approximately $3.3 million, which will be recorded primarily in the second quarter of 2026.

filing / May 12, 2026 / receipt

We lease approximately 37,000 square feet of office space in Philadelphia, Pennsylvania, or the 2005 Market Street Lease Agreement.

filing / May 12, 2026 / receipt

In January 2025, the Company announced a workforce reduction to reduce operating expenses and to extend its cash runway.

filing / May 12, 2026 / receipt